Wikidata

(Q63320802)

English

Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients

clinical trial

In more languages

Statements

title
A Randomized, 24-week, Open-label, 2-arm Parallel-group, Multicenter Study Comparing the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine on Top of Metformin in Type 2 Diabetic Patients (English)
0 references
sponsor
Sanofi
0 references
country
Chile
0 references
Czech Republic
0 references
Denmark
0 references
France
0 references
Germany
0 references
Hungary
0 references
Lithuania
0 references
Mexico
0 references
Poland
0 references
Romania
0 references
Slovakia
0 references
Sweden
0 references
start time
November 2011
0 references
end time
December 2012
0 references
number of participants
323
0 references
research intervention
metformin
0 references
insulin glargine
0 references
lixisenatide
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63320802&oldid=1857133229"